The impact of targeted malaria elimination with mass drug administrations on falciparum malaria in southeast Asia: A cluster randomised trial

PLoS Medicine

Volumn 16, Issue 2, 2019, Pages

  von Seidlein, Lorenz ^a,b   Peto, Thomas J ^a,b   Landier, Jordi ^c,d   Nguyen, Thuy Nhien ^e   Tripura, Rupam ^a,b,f   Phommasone, Koukeo ^g,h   Pongvongsa, Tiengkham ^a,i   Lwin, Khin Maung ^c   Keereecharoen, Lilly ^c   Kajeechiwa, Ladda ^c   Thwin, May Myo ^c   Parker, Daniel M ^c,j   Wiladphaingern, Jacher ^c   Nosten, Suphak ^c   Proux, Stephane ^c   Corbel, Vincent ^k   Tuong Vy, Nguyen ^e   Phuc Nhi, Truong Le ^e   Son, Do Hung ^e   Huong Thu, Pham Nguyen ^e   Tuyen, Nguyen Thi Kim ^e   Tien, Nguyen Thanh ^e   Dong, Le Thanh ^l   Van Hue, Dao ^m   Quang, Huynh Hong ^l   Nguon, Chea ⁿ   Davoeung, Chan ^o   Rekol, Huy ⁿ   Adhikari, Bipin ^a,b   Henriques, Gisela ^a,p   Phongmany, Panom ⁱ   Suangkanarat, Preyanan ^g   Jeeyapant, Atthanee ^a   Vihokhern, Benchawan ^a   van der Pluijm, Rob W ^a,b   Lubell, Yoel ^a,b   White, Lisa J ^a,b   Aguas, Ricardo ^a,b   Promnarate, Cholrawee ^a   Sirithiranont, Pasathorn ^a   Malleret, Benoit ^q,r   Rénia, Laurent ^r   Onsjö, Carl ^a,s   Chan, Xin Hui ^a,b   Chalk, Jeremy ^a   Miotto, Olivo ^a,t   Patumrat, Krittaya ^a   Chotivanich, Kesinee ^a   Hanboonkunupakarn, Borimas ^a   Jittmala, Podjanee ^a   Kaehler, Nils ^a   Cheah, Phaik Yeong ^a,b   Pell, Christopher ^h   Dhorda, Mehul ^a   Imwong, Mallika ^a   Snounou, Georges ^u   Mukaka, Mavuto ^a,b   Peerawaranun, Pimnara ^a   Lee, Sue J ^a,b   Simpson, Julie A ^v   Pukrittayakamee, Sasithon ^a,w   Singhasivanon, Pratap ^a   Grobusch, Martin P ^f   Cobelens, Frank ^h   Smithuis, Frank ^x   Newton, Paul N ^b,g   Thwaites, Guy E ^b,e   Day, Nicholas P J ^a,b   Mayxay, Mayfong ^g,y   Hien, Tran Tinh ^b,d   Nosten, Francois H ^b,c   Dondorp, Arjen M ^a,b   White, Nicholas J ^a,b   more..

^a MAHIDOL UNIVERSITY   (Thailand)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c SHOKLO MALARIA RESEARCH UNIT   (Thailand)

^d AIX MARSEILLE UNIVERSITY   (France)

^e OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^f ACADEMIC MEDICAL CENTER   (Netherlands)

^g MAHOSOT HOSPITAL   (Laos)

^h AMSTERDAM INSTITUTE FOR GLOBAL HEALTH AND DEVELOPMENT   (Netherlands)

ⁱ Savannakhet Provincial Health Department   (Laos)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k UNIV MONTPELLIER   (France)

^l Institute of Malariology Parasitology and Entomology   (Viet Nam)

^m Parasitology and Entomology   (Viet Nam)

ⁿ National Center for Parasitology Entomology and Malaria Control   (Cambodia)

^o Provincial Health Department   (Cambodia)

^p LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^q NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^r AGENCY FOR SCIENCE   (Singapore)

^s LINKÖPING UNIVERSITY   (Sweden)

^t WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^u INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^v UNIVERSITY OF MELBOURNE   (Australia)

^w Endocrine Society of Thailand   (Thailand)

^x Myanmar Oxford Clinical Research Unit   (Myanmar)

^y UNIVERSITY OF HEALTH SCIENCES   (Laos)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROARTEMISININ PLUS PIPERAQUINE; ANTIMALARIAL AGENT;

ADULT; ANTIMALARIAL DRUG RESISTANCE; ARTICLE; BLOOD SAMPLING; BODY HEIGHT; BODY SURFACE; BODY WEIGHT; CELL HETEROGENEITY; CLINICAL TRIAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE SURVEILLANCE; DIZZINESS; DNA EXTRACTION; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HEALTH SURVEY; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; PARASITE CLEARANCE; PARASITE PREVALENCE; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PRURITUS; RANDOMIZED CONTROLLED TRIAL; REPEATED DRUG DOSE; SOUTHEAST ASIA; STRUCTURED QUESTIONNAIRE; VOMITING; ADOLESCENT; CHILD; CLUSTER ANALYSIS; CROSSOVER PROCEDURE; DISEASE ERADICATION; DRUG EFFECT; MASS DRUG ADMINISTRATION; MULTIDRUG RESISTANCE; PHYSIOLOGY; PROCEDURES; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIMALARIALS; ASIA, SOUTHEASTERN; CHILD; CLUSTER ANALYSIS; CROSS-OVER STUDIES; DISEASE ERADICATION; DRUG RESISTANCE, MULTIPLE; FEMALE; HUMANS; MALARIA, FALCIPARUM; MALE; MASS DRUG ADMINISTRATION; YOUNG ADULT;

EID: 85061580866     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1002745     Document Type: Article

References (73)

1. Bulchis A, Larson E. Sri Lanka celebrates malaria-free certification after long history of malaria control. San Francisco: Malaria Elimination Initiative; 2016 Sep 6 [cited 2019 Jan 18]. Available: http://www. shrinkingthemalariamap.org/news-blog/blog/sri-lanka-celebrates-malaria-free-certification-after-long-history-malaria-control.
2. Hemingway J, Ranson H, Magill A, Kolaczinski J, Fornadel C, Gimnig J, et al. Averting a malaria disaster: will insecticide resistance derail malaria control? Lancet. 2016; 387(10029):1785–8. https://doi.org/10.1016/S0140-6736(15)00417-1 PMID: 26880124
3. Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2014; 371(5):411–23. https://doi.org/10.1056/NEJMoa1314981 PMID: 25075834
4. Amaratunga C, Lim P, Suon S, Sreng S, Mao S, Sopha C, et al. Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study. Lancet Infect Dis. 2016; 16(3):357–65. https://doi.org/10.1016/S1473-3099(15)00487-9 PMID: 26774243
5. Duru V, Khim N, Leang R, Kim S, Domergue A, Kloeung N, et al. Plasmodium falciparum dihydroartemisinin-piperaquine failures in Cambodia are associated with mutant K13 parasites presenting high survival rates in novel piperaquine in vitro assays: retrospective and prospective investigations. BMC Med. 2015; 13:305. https://doi.org/10.1186/s12916-015-0539-5 PMID: 26695060
6. Spring MD, Lin JT, Manning JE, Vanachayangkul P, Somethy S, Bun R, et al. Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study. Lancet Infect Dis. 2015; 15(6):683–91. https://doi.org/10.1016/S1473-3099(15)70049-6 PMID: 25877962
7. Mita T, Tanabe K. Evolution of Plasmodium falciparum drug resistance: implications for the development and containment of artemisinin resistance. Jpn J Infect Dis. 2012; 65(6):465–75. PMID: 23183197
8. Imwong M, Hien TT, Thuy-Nhien NT, Dondorp AM, White NJ. Spread of a single multidrug resistant malaria parasite lineage (PfPailin) to Vietnam. Lancet Infect Dis. 2017; 17(10):1022–3. https://doi.org/10.1016/S1473-3099(17)30524-8 PMID: 28948924
9. Imwong M, Suwannasin K, Kunasol C, Sutawong K, Mayxay M, Rekol H, et al. The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study. Lancet Infect Dis. 2017; 17(5):491–7. https://doi.org/10.1016/S1473-3099(17) 30048-8 PMID: 28161569
10. Newby G, Hwang J, Koita K, Chen I, Greenwood B, von Seidlein L, et al. Review of mass drug administration for malaria and its operational challenges. Am J Trop Med Hyg. 2015; 93(1):125–34. https://doi. org/10.4269/ajtmh.14-0254 PMID: 26013371
11. von Seidlein L, Greenwood BM. Mass administrations of antimalarial drugs. Trends Parasitol. 2003; 19 (10):452–60. PMID: 14519583
12. Poirot E, Skarbinski J, Sinclair D, Kachur SP, Slutsker L, Hwang J. Mass drug administration for malaria. Cochrane Database Syst Rev. 2013; 12:CD008846. https://doi.org/10.1002/14651858. CD008846.pub2 PMID: 24318836
13. Kaneko A, Taleo G, Kalkoa M, Yamar S, Kobayakawa T, Bjorkman A. Malaria eradication on islands. Lancet. 2000; 356(9241):1560–4. https://doi.org/10.1016/S0140-6736(00)03127-5 PMID: 11075770
14. Eisele TP, Bennett A, Silumbe K, Finn TP, Chalwe V, Kamuliwo M, et al. Short-term impact of mass drug administration with dihydroartemisinin plus piperaquine on malaria in Southern Province Zambia: a cluster-randomized controlled trial. J Infect Dis. 2016; 214(12):1831–9. https://doi.org/10.1093/infdis/jiw416 PMID: 27923947
15. Deng C, Huang B, Wang Q, Wu W, Zheng S, Zhang H, et al. Large-scale artemisinin-piperaquine mass drug administration with or without primaquine dramatically reduces malaria in a highly endemic region of Africa. Clin Infect Dis. 2018; 67(11):1670–6. https://doi.org/10.1093/cid/ciy364 PMID: 29846536
16. Chakir I, Said AI, Affane B, Jambou R. Control of malaria in the Comoro Islands over the past century. Malar J. 2017; 16(1):387. https://doi.org/10.1186/s12936-017-2027-1 PMID: 28950864
17. Luxemburger C, Thwai KL, White NJ, Webster HK, Kyle DE, Maelankirri L, et al. The epidemiology of malaria in a Karen population on the western border of Thailand. Trans R Soc Trop Med Hyg. 1996; 90 (2):105–11. PMID: 8761562
18. Paul RE, Hackford I, Brockman A, Muller-Graf C, Price R, Luxemburger C, et al. Transmission intensity and Plasmodium falciparum diversity on the northwestern border of Thailand. Am J Trop Med Hyg. 1998; 58(2):195–203. PMID: 9502604
19. Carrara VI, Lwin KM, Phyo AP, Ashley E, Wiladphaingern J, Sriprawat K, et al. Malaria burden and artemisinin resistance in the mobile and migrant population on the Thai-Myanmar border, 1999–2011: an observational study. PLoS Med. 2013; 10(3):e1001398. https://doi.org/10.1371/journal.pmed.1001398 PMID: 23472056
20. Kwansomboon N, Chaumeau V, Kittiphanakun P, Cerqueira D, Corbel V, Chareonviriyaphap T. Vector bionomics and malaria transmission along the Thailand-Myanmar border: a baseline entomological survey. J Vector Ecol. 2017; 42(1):84–93. https://doi.org/10.1111/jvec.12242 PMID: 28504441
21. Landier J, Parker DM, Thu AM, Lwin KM, Delmas G, Nosten FH, et al. Effect of generalised access to early diagnosis and treatment and targeted mass drug administration on Plasmodium falciparum malaria in Eastern Myanmar: an observational study of a regional elimination programme. Lancet. 2018; 391(10133):1916–26. https://doi.org/10.1016/S0140-6736(18)30792-X PMID: 29703425
22. Imwong M, Nguyen TN, Tripura R, Peto TJ, Lee SJ, Lwin KM, et al. The epidemiology of subclinical malaria infections in South-East Asia: findings from cross-sectional surveys in Thailand-Myanmar border areas, Cambodia, and Vietnam. Malar J. 2015; 14:381. https://doi.org/10.1186/s12936-015-0906-x PMID: 26424000
23. Landier J, Kajeechiwa L, Thwin MM, Parker DM, Chaumeau V, Wiladphaingern J, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: a pilot trial in four villages of Eastern Myanmar. Wellcome Open Res. 2017; 2:81. https://doi. org/10.12688/wellcomeopenres.12240.1 PMID: 29062913
24. Goldlust SM, Thuan PD, Giang DDH, Thang ND, Thwaites GE, Farrar J, et al. The decline of malaria in Vietnam, 1991–2014. Malar J. 2018; 17(1):226. https://doi.org/10.1186/s12936-018-2372-8 PMID: 29880051
25. Hien TT, Thuy-Nhien NT, Phu NH, Boni MF, Thanh NV, Nha-Ca NT, et al. In vivo susceptibility of Plasmodium falciparum to artesunate in Binh Phuoc Province, Vietnam. Malar J. 2012; 11:355. https://doi. org/10.1186/1475-2875-11-355 PMID: 23101492
26. Thanh NV, Thuy-Nhien N, Tuyen NT, Tong NT, Nha-Ca NT, Dong LT, et al. Rapid decline in the susceptibility of Plasmodium falciparum to dihydroartemisinin-piperaquine in the south of Vietnam. Malar J. 2017; 16(1):27. https://doi.org/10.1186/s12936-017-1680-8 PMID: 28086775
27. Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM. Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med. 2008; 359(24):2619–20. https://doi.org/10.1056/NEJMc0805011 PMID: 19064625
28. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009; 361(5):455–67. https://doi.org/10.1056/NEJMoa0808859 PMID: 19641202
29. World Health Organization. World malaria report 2012. Geneva: World Health Organization; 2012.
30. World Health Organization. Global plan for artemisinin resistance containment. Geneva: World Health Organization; 2012.
31. World Health Organization. Emergency response plan to artemisinin resistance in the Greater Mekong Subregion. Geneva: World Health Organization; 2013.
32. Hoyer S, Nguon S, Kim S, Habib N, Khim N, Sum S, et al. Focused Screening and Treatment (FSAT): a PCR-based strategy to detect malaria parasite carriers and contain drug resistant P. falciparum, Pailin, Cambodia. PLoS ONE. 2012; 7(10):e45797. https://doi.org/10.1371/journal.pone.0045797 PMID: 23049687
33. Cook J, Speybroeck N, Sochanta T, Somony H, Sokny M, Claes F, et al. Sero-epidemiological evaluation of changes in Plasmodium falciparum and Plasmodium vivax transmission patterns over the rainy season in Cambodia. Malar J. 2012; 11:86. https://doi.org/10.1186/1475-2875-11-86 PMID: 22443375
34. Tripura R, Peto TJ, Veugen CC, Nguon C, Davoeung C, James N, et al. Submicroscopic Plasmodium prevalence in relation to malaria incidence in 20 villages in western Cambodia. Malar J. 2017; 16(1):56. https://doi.org/10.1186/s12936-017-1703-5 PMID: 28143518
35. Tripura R, Peto TJ, Nguon C, Davoeung C, Mukaka M, Sirithiranont P, et al. A controlled trial of mass drug administration to interrupt transmission of multi drug resistant falciparum malaria in Cambodian villages. Clin Infect Dis. 2018; 67(6):817–26. https://doi.org/10.1093/cid/ciy196 PMID: 29522113
36. Lao People’s Democratic Republic Ministry of Health. National strategic plan for malaria control and elimination 2016–2020. Lao People’s Democratic Republic Ministry of Health; 2016 [cited 2019 Jan 18]. Available: http://www.malariafreemekong.org/2017/08/02/lao-pdr-2016-2020/.
37. Phommasone K, Adhikari B, Henriques G, Pongvongsa T, Phongmany P, von Seidlein L, et al. Asymp-tomatic Plasmodium infections in 18 villages of southern Savannakhet Province, Lao PDR (Laos). Malar J. 2016; 15(1):296. https://doi.org/10.1186/s12936-016-1336-0 PMID: 27234446
38. Kajeechiwa L, Thwin MM, Nosten S, Tun SW, Parker D, von Seidlein L, et al. Community engagement for the rapid elimination of malaria: the case of Kayin State, Myanmar. Wellcome Open Res. 2017; 2:59. https://doi.org/10.12688/wellcomeopenres.12051.1 PMID: 28894847
39. Nguyen TN, Thu PN, Hung NT, Son DH, Tien NT, Van Dung N, et al. Community perceptions of targeted anti-malarial mass drug administrations in two provinces in Vietnam: a quantitative survey. Malar J. 2017; 16(1):17. https://doi.org/10.1186/s12936-016-1662-2PMID: 28061908
40. Adhikari B, Phommasone K, Pongvongsa T, Kommarasy P, Soundala X, Henriques G, et al. Factors associated with population coverage of targeted malaria elimination (TME) in southern Savannakhet Province, Lao PDR. Malar J. 2017; 16(1):424. https://doi.org/10.1186/s12936-017-2070-y PMID: 29061133
41. Pell C, Tripura R, Nguon C, Cheah P, Davoeung C, Heng C, et al. Mass anti-malarial administration in western Cambodia: a qualitative study of factors affecting coverage. Malar J. 2017; 16(1):206. https://doi.org/10.1186/s12936-017-1854-4 PMID: 28526019
42. Sahan K, Pell C, Smithuis F, Phyo AK, Maung SM, Indrasuta C, et al. Community engagement and the social context of targeted malaria treatment: a qualitative study in Kayin (Karen) State, Myanmar. Malar J. 2017; 16(1):75. https://doi.org/10.1186/s12936-017-1718-y PMID: 28196536
43. Adhikari B, James N, Newby G, von Seidlein L, White NJ, Day NP, et al. Community engagement and population coverage in mass anti-malarial administrations: a systematic literature review. Malar J. 2016; 15(1):523. https://doi.org/10.1186/s12936-016-1593-y
44. Peto TJ, Tripura R, Davoeung C, Nguon C, Nou S, Heng C, et al. Reflections on a community engagement strategy for mass antimalarial drug administration in Cambodia. Am J Trop Med Hyg. 2018; 98 (1):100–4. https://doi.org/10.4269/ajtmh.17-0428 PMID: 29165227
45. Adhikari B, Pell C, Phommasone K, Soundala X, Kommarasy P, Pongvongsa T, et al. Elements of effective community engagement: lessons from a targeted malaria elimination study in Lao PDR (Laos). Glob Health Action. 2017; 10(1):1366136. https://doi.org/10.1080/16549716.2017.1366136 PMID: 28914184
46. Grundy PM, Healy MJR. Restricted randomization and quasi-Latin squares. J R Stat Soc Series B Stat Methodol. 1950; 12:215–7.
47. von Seidlein L, Dondorp A. Fighting fire with fire: mass antimalarial drug administrations in an era of antimalarial resistance. Expert Rev Anti Infect Ther. 2015; 13(6):715–30. https://doi.org/10.1586/14787210.2015.1031744 PMID: 25831482
48. Ashley EA, Recht J, White NJ. Primaquine: the risks and the benefits. Malar J. 2014; 13:418. https://doi. org/10.1186/1475-2875-13-418 PMID: 25363455
49. Hanboonkunupakarn B, Ashley EA, Jittamala P, Tarning J, Pukrittayakamee S, Hanpithakpong W, et al. Open-label crossover study of primaquine and dihydroartemisinin-piperaquine pharmacokinetics in healthy adult Thai subjects. Antimicrob Agents Chemother. 2014; 58(12):7340–6. https://doi.org/10. 1128/AAC.03704-14 PMID: 25267661
50. White NJ, Qiao LG, Qi G, Luzzatto L. Rationale for recommending a lower dose of primaquine as a Plasmodium falciparum gametocytocide in populations where G6PD deficiency is common. Malar J. 2012; 11:418. https://doi.org/10.1186/1475-2875-11-418 PMID: 23237606
51. Sutanto I, Suprijanto S, Kosasih A, Dahlan MS, Syafruddin D, Kusriastuti R, et al. The effect of primaquine on gametocyte development and clearance in the treatment of uncomplicated falciparum malaria with dihydroartemisinin-piperaquine in South Sumatra, Western Indonesia: an open-label, randomized, controlled trial. Clin Infect Dis. 2013; 56(5):685–93. https://doi.org/10.1093/cid/cis959 PMID: 23175563
52. Imwong M, Hanchana S, Malleret B, Renia L, Day NP, Dondorp A, et al. High throughput ultra-sensitive molecular techniques to quantify low density malaria parasitaemias. J Clin Microbiol. 2014; 9(52):3003– 9. https://doi.org/10.1128/JCM.01057-14
53. Kamau E, Tolbert LS, Kortepeter L, Pratt M, Nyakoe N, Muringo L, et al. Development of a highly sensitive genus-specific quantitative reverse transcriptase real-time PCR assay for detection and quantita-tion of plasmodium by amplifying RNA and DNA of the 18S rRNA genes. J Clin Microbiol. 2011; 49 (8):2946–53. https://doi.org/10.1128/JCM.00276-11 PMID: 21653767
54. Imwong M, Snounou G, Pukrittayakamee S, Tanomsing N, Kim JR, Nandy A, et al. Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites. J Infect Dis. 2007; 195(7):927–33. https://doi.org/10.1086/512241 PMID: 17330781
55. Snounou G. Detection and identification of the four malaria parasite species infecting humans by PCR amplification. Methods Mol Biol. 1996; 50:263–91. PMID: 8751365
56. Amato R, Lim P, Miotto O. Genetic markers associated with dihydroartemisinin–piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype–phenotype association study. Lancet Infect Dis. 2017; 17:164–73. https://doi.org/10.1016/S1473-3099(16)30409-1 PMID: 27818095
57. Austin PC, Stryhn H, Leckie G, Merlo J. Measures of clustering and heterogeneity in multilevel Poisson regression analyses of rates/count data. Stat Med. 2018; 37(4):572–89. https://doi.org/10.1002/sim. 7532 PMID: 29114926
58. Phuc BQ, Rasmussen C, Duong TT, Dong LT, Loi MA, Menard D, et al. Treatment failure of dihydroar-temisinin/piperaquine for Plasmodium falciparum malaria, Vietnam. Emerg Infect Dis. 2017; 23(4):715– 7. https://doi.org/10.3201/eid2304.161872 PMID: 28322709
59. Chaumeau V, Kajeechiwa L, Fustec B, Landier J, Nyo SN, Hsel SN, et al. The contribution of asymp-tomatic Plasmodium infections to the transmission of malaria in Kayin state, Myanmar. J Infect Dis. 2018 Nov 29. https://doi.org/10.1093/infdis/jiy686 PMID: 30500927
60. Smithuis FM, Kyaw MK, Phe UO, van der Broek I, Katterman N, Rogers C, et al. The effect of insecti-cide-treated bed nets on the incidence and prevalence of malaria in children in an area of unstable seasonal transmission in western Myanmar. Malar J. 2013; 12:363. https://doi.org/10.1186/1475-2875-12-363 PMID: 24119916
61. Ya-Umphan P, Cerqueira D, Cottrell G, Parker DM, Fowkes FJI, Nosten F, et al. Anopheles salivary biomarker as a proxy for estimating plasmodium falciparum malaria exposure on the Thailand-Myanmar border. Am J Trop Med Hyg. 2018; 99(2):350–6. https://doi.org/10.4269/ajtmh.18-0081 PMID: 29869601
62. Ya-Umphan P, Cerqueira D, Parker DM, Cottrell G, Poinsignon A, Remoue F, et al. Use of an Anopheles salivary biomarker to assess malaria transmission risk along the Thailand-Myanmar border. J Infect Dis. 2017; 215(3):396–404. https://doi.org/10.1093/infdis/jiw543PMID: 27932615
63. Durnez L, Mao S, Denis L, Roelants P, Sochantha T, Coosemans M. Outdoor malaria transmission in forested villages of Cambodia. Malar J. 2013; 12:329. https://doi.org/10.1186/1475-2875-12-329 PMID: 24044424
64. Gryseels C, Durnez L, Gerrets R, Uk S, Suon S, Set S, et al. Re-imagining malaria: heterogeneity of human and mosquito behaviour in relation to residual malaria transmission in Cambodia. Malar J. 2015; 14:165. https://doi.org/10.1186/s12936-015-0689-0 PMID: 25908498
65. Thanh PV, Van Hong N, Van Van N, Van Malderen C, Obsomer V, Rosanas-Urgell A, et al. Epidemiology of forest malaria in Central Vietnam: the hidden parasite reservoir. Malar J. 2015; 14:86. https://doi. org/10.1186/s12936-015-0601-y PMID: 25880664
66. Simpson SH, Eurich DT, Majumdar SR, Padwal RS, Tsuyuki RT, Varney J, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006; 333(7557):15. https://doi. org/10.1136/bmj.38875.675486.55 PMID: 16790458
67. Chewning B. The healthy adherer and the placebo effect. BMJ. 2006; 333(7557):18–9. https://doi.org/10.1136/bmj.333.7557.18 PMID: 16809709
68. Aguas R, Maude RJ, Gomes MGM, White LJ, White NJ, Dondorp AM. Infectivity of chronic malaria infections and its consequences for control and elimination. Clin Infect Dis. 2018; 67(2):295–302. https://doi.org/10.1093/cid/ciy055 PMID: 29757358
69. McLean ARD, Wai HP, Thu AM, Khant ZS, Indrasuta C, Ashley EA, et al. Malaria elimination in remote communities requires integration of malaria control activities into general health care: an observational study and interrupted time series analysis in Myanmar. BMC Med. 2018; 16(1):183. https://doi.org/10. 1186/s12916-018-1172-x PMID: 30343666
70. Taylor AR, Schaffner SF, Cerqueira GC, Nkhoma SC, Anderson TJC, Sriprawat K, et al. Quantifying connectivity between local Plasmodium falciparum malaria parasite populations using identity by descent. PLoS Genet. 2017; 13(10):e1007065. https://doi.org/10.1371/journal.pgen.1007065 PMID: 29077712
71. Omedo I, Mogeni P, Bousema T, Rockett K, Amambua-Ngwa A, Oyier I, et al. Micro-epidemiological structuring of Plasmodium falciparum parasite populations in regions with varying transmission intensities in Africa. Wellcome Open Res. 2017; 2:10. https://doi.org/10.12688/wellcomeopenres.10784.2 PMID: 28612053
72. Pinilla YT, Lopes SCP, Sampaio VS, Andrade FS, Melo GC, Orfano AS, et al. Promising approach to reducing Malaria transmission by ivermectin: sporontocidal effect against Plasmodium vivax in the South American vectors Anopheles aquasalis and Anopheles darlingi. PLoS Negl Trop Dis. 2018; 12 (2):e0006221. https://doi.org/10.1371/journal.pntd.0006221 PMID: 29444080
73. Tun STT, von Seidlein L, Pongvongsa T, Mayxay M, Saralamba S, Kyaw SS, et al. Towards malaria elimination in Savannakhet, Lao PDR: mathematical modelling driven strategy design. Malar J. 2017; 16(1):483. https://doi.org/10.1186/s12936-017-2130-3PMID: 29183370